University of California San Francisco
Give to UCSF
AIDS 2012 Draws Thousands to Nation's Capitol
<p><span>Bill and Hillary Clinton, Sharon Stone, Kathleen Sebelius, Bill Gates and Elton John are a few of the headliners to speak this week at AIDS 2012, the XIX International AIDS Conference, which runs through July 27 in Washington, D.C.</span></p>
UCSF/SFGH Researchers Call for Change in New FDA Recommendation on HIV and TB Drug Doses
In January 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease.
Health Campaign Shows Universal HIV Testing Can Be Extended for Early Identification of Other Diseases
A clinical study in a remote region of southwest Uganda has demonstrated the feasibility of using a health campaign to rapidly test a community for HIV and simultaneously offer prevention and diagnosis for a variety of other diseases in rural and resource-poor settings of sub-Saharan Africa.
Warner Greene Authors HIV/AIDS Medicine Textbook for Developing World
Warner C. Greene, MD, a professor of medicine, microbiology and immunology at UCSFwho directs virology and immunology research at the UCSF-affiliated Gladstone Institutes, has joined with other global AIDS experts to release a locally affordable version of the world’s leading AIDS medical textbook.
Hair Samples from Infants Show Exposure to Anti-HIV Drugs in the Womb and During Breast-feeding
Researchers from the University of California, San Francisco (UCSF) and Makerere University in Uganda have used hair and blood samples from three-month old infants born to HIV-positive mothers to measure the uninfected babies’ exposure — both in the womb and from breast-feeding — to antiretroviral medications their mothers were taking. The results, they said, are surprising.
HIV/AIDS Prevention with Truvada: How Pregnant Women and Others May Benefit
<p>The AIDS drug Truvada, approved this week for prevention of HIV infection in uninfected people at high risk, may benefit many uninfected women whose male partners have HIV, including pregnant women, who may be at higher risk.</p>